Jiangxi Bio rises 8% on vet antitoxin approvalHK Stock Market UpdateJul 15, 2026 at 05:40 AMJiangxi Bio (6915.HK) climbed 8% during regular trading to HK$4.890.The surge followed news that a subsidiary recently received approval for veterinary tetanus antitoxin, serving as the primary catalyst for the stock's movement.
